Discovery of Potent Cyclophilin Inhibitors Based on the Structural Simplification of Sanglifehrin A.
Steadman, V.A., Pettit, S.B., Poullennec, K.G., Lazarides, L., Keats, A.J., Dean, D.K., Stanway, S.J., Austin, C.A., Sanvoisin, J.A., Watt, G.M., Fliri, H.G., Liclican, A.C., Jin, D., Wong, M.H., Leavitt, S.A., Lee, Y.J., Tian, Y., Frey, C.R., Appleby, T.C., Schmitz, U., Jansa, P., Mackman, R.L., Schultz, B.E.(2017) J Med Chem 60: 1000-1017
- PubMed: 28075591 
- DOI: 10.1021/acs.jmedchem.6b01329
- Primary Citation of Related Structures:  
5T9U, 5T9W, 5T9Z, 5TA2, 5TA4 - PubMed Abstract: 
Cyclophilin inhibition has been a target for the treatment of hepatitis C and other diseases, but the generation of potent, drug-like molecules through chemical synthesis has been challenging. In this study, a set of macrocyclic cyclophilin inhibitors was synthesized based on the core structure of the natural product sanglifehrin A ...